NCT03586401

Brief Summary

The purpose of this study is to create a software product on the basis of the support technologies for making decisions for the collaboration of the different specialists, the family and the patient himself in the process of physical therapy of children treated for cancer. The basic model of the technology is a qualification model of the state of health and physical limitations, based on data from a survey of 1,000 children treated for cancer. The software product is supposed to be created on the basis of the Splunk system, the key link is a personal office with a two-way login system: for specialists and for patients. The patient introduces the results of self-examination, monitoring and additional surveys in real time, specialists - additional recommendations. To assess the effectiveness of the collaboration based on the software product, a long-term follow-up (at least 3 years) is planned for the participants of the study with repeated examinations at the Medical-Rehabilitation Scientific Center "Russe pole" at least twice a year. Condition or disease Hemoblastosis Solid brain tumors The condition after hematopoietic stem cell transplantation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 13, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2020

Completed
Last Updated

July 13, 2018

Status Verified

June 1, 2018

Enrollment Period

1.6 years

First QC Date

May 25, 2018

Last Update Submit

July 2, 2018

Conditions

Keywords

Children who have been treated for cancerQualification of healthPhysical insolvencyLate toxic effectsPhysical therapyPhysical activitySystems for decision making support

Outcome Measures

Primary Outcomes (1)

  • Self-assessment of motor activity

    Based on The International Physical Activity Questionnaire (IPAQ). The patient or his parents fill out a special questionnaire, that contains questions about the motor activity in 4 areas: leisure, activity at home and in the garden, activities related to work and activities related to transport. The main indicator is the the MET (Metabolic Equivalent of Task) per week: MET level x minutes of activity x events per week. Three levels (categories) of physical activity are proposed. High - 7 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 3000 MET-minutes/week Moderate - 5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 600 MET-min/week. Low - Those individuals who not meet criteria for categories 1 or 2 are considered low/inactive.

    at least 12 studies with an interval of not more than 2 months, a total period of 2 years

Secondary Outcomes (9)

  • Myocardial contractility

    at least 4 studies with an interval of not more than 6 months, a total period - 2 years

  • The response of the vascular system to submaximal load (6-minute walk test)

    at least 4 studies with an interval of not more than 6 months, a total period - 2 years

  • The neuromuscular support of physical activity

    at least 4 studies with an interval of not more than 6 months, a total period - 2 years

  • Strength endurance of the main muscle groups

    at least 4 studies with an interval of not more than 6 months, a total period - 2 years

  • Energy costs for physical activity

    at least 4 studies with an interval of not more than 6 months, a total period - 2 years

  • +4 more secondary outcomes

Study Arms (1)

Childhood Cancer Survivors

The study will be attended by 1000 families with children who have completed treatment for cancer at least 6 months before the start of the trial and undergo rehabilitation courses at the Medical and Rehabilitation Research Center "Russkoe pole" at least twice a year.

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study will be attended by 1000 families with children who have completed treatment for cancer on at least 6 months before the start of the trial and undergo rehabilitation courses at the Medical-Rehabilitation Research Center "Russkoe pole" at least twice a year.

You may qualify if:

  • Signing of the agreement with the Medical-Rehabilitation Scientific Center "Russkoe pole".
  • Persistent remission not less than 6 months after.
  • Age not less than 4 years and not more than 16 years at the time of signing the agreement on participation in the protocol.
  • Collaboration with the patient's family and the patient.

You may not qualify if:

  • The occurence of second tumors.
  • Recurrence of cancer.
  • Failure to fulfill the obligations under the contract, failure to attend the next survey.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology

Moscow, 117997, Russia

RECRUITING

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Vladimir N. Kasatkin, professor

    The National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Ministry of Health of the Russian Federation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Serafima M. Chechelnitskaya, professor

CONTACT

Alexandra V. Baerbakh

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Physical Rehabilitation Department

Study Record Dates

First Submitted

May 25, 2018

First Posted

July 13, 2018

Study Start

November 1, 2017

Primary Completion

May 21, 2019

Study Completion

May 21, 2020

Last Updated

July 13, 2018

Record last verified: 2018-06

Locations